Global Complex Regional Pain Syndrome (CRPS) Treatment Market
Market Status, Strategic Analysis & Forecast (2026–2036)
Market Overview
Complex Regional Pain Syndrome (CRPS) is a chronic, progressive pain condition characterized by severe pain, inflammation, sensory abnormalities, and motor dysfunction, often following trauma or surgery. Due to its multifactorial pathophysiology—involving neurogenic inflammation, immune dysregulation, and central sensitization—the treatment landscape remains complex and largely unmet.
The global CRPS treatment market was valued at USD XX million in 2020 and is projected to reach USD XX million by 2036, expanding at a CAGR of XX% during 2026–2036. Market growth is supported by increasing disease recognition, advances in neuropathic pain therapeutics, and rising investments in rare and orphan pain disorders.
Segments Analysis
By Product / Drug Type
-
T-121
Novel centrally acting analgesic candidates -
NTRX-07
Targeted neuropathic pain modulation therapies -
Neridronic Acid
Bisphosphonate-based therapy with established clinical use in CRPS -
Other Therapies
Includes corticosteroids, anticonvulsants, antidepressants, NMDA antagonists, and emerging biologics
By Drug Class (Expanded Segmentation)
-
Bisphosphonates
-
NMDA Receptor Antagonists
-
Anticonvulsants
-
Antidepressants
-
Opioid & Non-Opioid Analgesics
-
Anti-Inflammatory Agents
By Route of Administration (New Segment)
-
Oral
-
Intravenous
-
Intrathecal
-
Topical
By Application / End User
-
Hospitals
Primary centers for diagnosis and advanced pain management -
Clinics
Pain management and specialty neurology clinics -
Others
Rehabilitation centers and home-care settings
Key Market Players
Major Manufacturers
-
Abiogen Pharma SpA
-
Axsome Therapeutics Inc
-
Grünenthal GmbH
-
Mallinckrodt Plc
Additional & Emerging Players (Added)
-
Pfizer
-
Novartis
-
Eli Lilly
-
Teva Pharmaceutical Industries
-
Johnson & Johnson
Regional Analysis
North America
-
Dominant market share
-
High disease awareness and specialist availability
-
Strong adoption of advanced pain therapeutics
Europe
-
Established use of bisphosphonates in CRPS
-
Supportive reimbursement in select countries
-
Active clinical research environment
Asia-Pacific
-
Fastest-growing regional market
-
Improving diagnostic rates and healthcare infrastructure
-
Increasing pharmaceutical R&D activity
Central & South America
-
Gradual adoption of standardized pain management protocols
-
Market growth supported by tertiary hospitals
Middle East & Africa
-
Emerging market with limited specialist access
-
Growth driven by urban healthcare expansion
Porter’s Five Forces Analysis
| Force | Impact |
|---|---|
| Threat of New Entrants | Low (high clinical complexity, regulatory barriers) |
| Bargaining Power of Suppliers | Medium |
| Bargaining Power of Buyers | High (hospitals and payers) |
| Threat of Substitutes | Medium (off-label pain therapies) |
| Competitive Rivalry | Medium–High |
SWOT Analysis
Strengths
-
Increasing recognition of CRPS as a distinct disorder
-
Growing focus on neuropathic pain mechanisms
-
Orphan-drug development incentives
Weaknesses
-
Lack of universally approved CRPS-specific therapies
-
Diagnostic complexity and under-reporting
-
Variable treatment outcomes
Opportunities
-
Development of disease-modifying therapies
-
Expansion of biologics and CNS-targeted drugs
-
Personalized pain management approaches
Threats
-
High clinical trial failure rates
-
Reimbursement and pricing pressures
-
Competition from off-label generics
Trend Analysis
-
Shift from symptomatic pain relief to mechanism-based therapies
-
Increased use of bisphosphonates and NMDA antagonists
-
Rising interest in central sensitization and immune pathways
-
Expansion of multimodal pain management strategies
-
Growing clinical trial activity in rare pain disorders
Market Drivers
-
Rising incidence of post-traumatic and post-surgical pain
-
Improved diagnostic awareness among clinicians
-
Increased investment in rare and orphan disease research
Market Challenges
-
Limited standardized treatment guidelines
-
High cost of advanced pain therapies
-
Long timelines for clinical validation
Value Chain Analysis
-
Drug Discovery & Preclinical Research
-
Clinical Development (Phase I–III)
-
Regulatory Review & Approval
-
Manufacturing & Quality Assurance
-
Distribution & Specialty Pharmacies
-
Hospitals, Clinics & Pain Centers
-
Patient Management & Rehabilitation
Quick Strategic Recommendations for Stakeholders
-
Pharmaceutical Companies: Invest in CNS-targeted and immune-modulating therapies
-
Healthcare Providers: Adopt multidisciplinary pain management models
-
Investors: Focus on orphan-drug pipelines and late-stage CRPS assets
-
Distributors: Strengthen specialty drug logistics
-
Policy Makers: Support rare pain disorder awareness and reimbursement
Conclusion
The Complex Regional Pain Syndrome Treatment Market remains a high-unmet-need and innovation-driven segment within the global pain management landscape. With advances in neurobiology, immune modulation, and precision medicine, the market is expected to witness steady long-term growth, particularly as targeted and disease-modifying therapies move closer to commercialization.
Table of Contents
Global Complex Regional Pain Syndrome Treatment Market Research Report 2026
1 Industry Overview of Complex Regional Pain Syndrome Treatment
1.1 Definition and Specifications of Complex Regional Pain Syndrome Treatment
1.1.1 Definition of Complex Regional Pain Syndrome Treatment
1.1.2 Specifications of Complex Regional Pain Syndrome Treatment
1.2 Classification of Complex Regional Pain Syndrome Treatment
1.2.1 T-121
1.2.2 NTRX-07
1.2.3 Neridronic Acid
1.2.4 Others
1.3 Applications of Complex Regional Pain Syndrome Treatment
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Complex Regional Pain Syndrome Treatment
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Complex Regional Pain Syndrome Treatment
2.3 Manufacturing Process Analysis of Complex Regional Pain Syndrome Treatment
2.4 Industry Chain Structure of Complex Regional Pain Syndrome Treatment
3 Technical Data and Manufacturing Plants Analysis of Complex Regional Pain Syndrome Treatment
3.1 Capacity and Commercial Production Date of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
3.3 R&D Status and Technology Source of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
4 Global Complex Regional Pain Syndrome Treatment Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Complex Regional Pain Syndrome Treatment Capacity and Growth Rate Analysis
4.2.2 Complex Regional Pain Syndrome Treatment Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Complex Regional Pain Syndrome Treatment Sales and Growth Rate Analysis
4.3.2 Complex Regional Pain Syndrome Treatment Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Complex Regional Pain Syndrome Treatment Sales Price
4.4.2 Complex Regional Pain Syndrome Treatment Sales Price Analysis (Company Segment)
5 Complex Regional Pain Syndrome Treatment Regional Market Analysis
5.1 North America Complex Regional Pain Syndrome Treatment Market Analysis
5.1.1 North America Complex Regional Pain Syndrome Treatment Market Overview
5.1.2 North America E Complex Regional Pain Syndrome Treatment Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Complex Regional Pain Syndrome Treatment Sales Price Analysis
5.1.4 North America Complex Regional Pain Syndrome Treatment Market Share Analysis
5.2 Europe Complex Regional Pain Syndrome Treatment Market Analysis
5.2.1 Europe Complex Regional Pain Syndrome Treatment Market Overview
5.2.2 Europe E Complex Regional Pain Syndrome Treatment Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Complex Regional Pain Syndrome Treatment Sales Price Analysis
5.2.4 Europe Complex Regional Pain Syndrome Treatment Market Share Analysis
5.3 China Complex Regional Pain Syndrome Treatment Market Analysis
5.3.1 China Complex Regional Pain Syndrome Treatment Market Overview
5.3.2 China E Complex Regional Pain Syndrome Treatment Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Complex Regional Pain Syndrome Treatment Sales Price Analysis
5.3.4 China Complex Regional Pain Syndrome Treatment Market Share Analysis
5.4 Japan Complex Regional Pain Syndrome Treatment Market Analysis
5.4.1 Japan Complex Regional Pain Syndrome Treatment Market Overview
5.4.2 Japan E Complex Regional Pain Syndrome Treatment Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Complex Regional Pain Syndrome Treatment Sales Price Analysis
5.4.4 Japan Complex Regional Pain Syndrome Treatment Market Share Analysis
5.5 Southeast Asia Complex Regional Pain Syndrome Treatment Market Analysis
5.5.1 Southeast Asia Complex Regional Pain Syndrome Treatment Market Overview
5.5.2 Southeast Asia E Complex Regional Pain Syndrome Treatment Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Complex Regional Pain Syndrome Treatment Sales Price Analysis
5.5.4 Southeast Asia Complex Regional Pain Syndrome Treatment Market Share Analysis
5.6 India Complex Regional Pain Syndrome Treatment Market Analysis
5.6.1 India Complex Regional Pain Syndrome Treatment Market Overview
5.6.2 India E Complex Regional Pain Syndrome Treatment Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Complex Regional Pain Syndrome Treatment Sales Price Analysis
5.6.4 India Complex Regional Pain Syndrome Treatment Market Share Analysis
6 Global E Complex Regional Pain Syndrome Treatment Segment Market Analysis (by Type)
6.1 Global E Complex Regional Pain Syndrome Treatment Sales by Type
6.2 Different Types of Complex Regional Pain Syndrome Treatment Product Interview Price Analysis
6.3 Different Types of Complex Regional Pain Syndrome Treatment Product Driving Factors Analysis
6.3.1 T-121 Growth Driving Factor Analysis
6.3.2 NTRX-07 Growth Driving Factor Analysis
6.3.3 Neridronic Acid Growth Driving Factor Analysis
6.3.4 Others Growth Driving Factor Analysis
7 Global E Complex Regional Pain Syndrome Treatment Segment Market Analysis (by Application)
7.1 Global E Complex Regional Pain Syndrome Treatment Consumption by Application
7.2 Different Application of Complex Regional Pain Syndrome Treatment Product Interview Price Analysis
7.3 Different Application of Complex Regional Pain Syndrome Treatment Product Driving Factors Analysis
7.3.1 Hospital of Complex Regional Pain Syndrome Treatment Growth Driving Factor Analysis
7.3.2 Clinic of Complex Regional Pain Syndrome Treatment Growth Driving Factor Analysis
7.3.3 Others of Complex Regional Pain Syndrome Treatment Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Complex Regional Pain Syndrome Treatment
8.1 Abiogen Pharma SpA
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Business Region Distribution Analysis
8.2 Axsome Therapeutics, Inc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Business Region Distribution Analysis
8.3 Grunenthal GmbH
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Grunenthal GmbH Complex Regional Pain Syndrome Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Grunenthal GmbH Complex Regional Pain Syndrome Treatment Business Region Distribution Analysis
8.4 Mallinckrodt Plc
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Business Region Distribution Analysis
9 Development Trend of Analysis of Complex Regional Pain Syndrome Treatment Market
9.1 Global Complex Regional Pain Syndrome Treatment Market Trend Analysis
9.1.1 Global 2018-2025 Complex Regional Pain Syndrome Treatment Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Complex Regional Pain Syndrome Treatment Sales Price Forecast
9.2 Complex Regional Pain Syndrome Treatment Regional Market Trend
9.2.1 North America 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Forecast
9.2.2 Europe 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Forecast
9.2.3 China 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Forecast
9.2.4 Japan 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Forecast
9.2.6 India 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Forecast
9.3 Complex Regional Pain Syndrome Treatment Market Trend (Product Type)
9.4 Complex Regional Pain Syndrome Treatment Market Trend (Application)
10 Complex Regional Pain Syndrome Treatment Marketing Type Analysis
10.1 Complex Regional Pain Syndrome Treatment Regional Marketing Type Analysis
10.2 Complex Regional Pain Syndrome Treatment International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Complex Regional Pain Syndrome Treatment by Region
10.4 Complex Regional Pain Syndrome Treatment Supply Chain Analysis
11 Consumers Analysis of Complex Regional Pain Syndrome Treatment
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Complex Regional Pain Syndrome Treatment Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Complex Regional Pain Syndrome Treatment
Table Product Specifications of Complex Regional Pain Syndrome Treatment
Table Classification of Complex Regional Pain Syndrome Treatment
Figure Global Production Market Share of Complex Regional Pain Syndrome Treatment by Type in
Figure T-121 Picture
Table Major Manufacturers of T-121
Figure NTRX-07 Picture
Table Major Manufacturers of NTRX-07
Figure Neridronic Acid Picture
Table Major Manufacturers of Neridronic Acid
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Complex Regional Pain Syndrome Treatment
Figure Global Consumption Volume Market Share of Complex Regional Pain Syndrome Treatment by Application in
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Complex Regional Pain Syndrome Treatment by Regions
Figure North America Complex Regional Pain Syndrome Treatment Market Size (Million USD) (2013-2025)
Figure Europe Complex Regional Pain Syndrome Treatment Market Size (Million USD) (2013-2025)
Figure China Complex Regional Pain Syndrome Treatment Market Size (Million USD) (2013-2025)
Figure Japan Complex Regional Pain Syndrome Treatment Market Size (Million USD) (2013-2025)
Figure Southeast Asia Complex Regional Pain Syndrome Treatment Market Size (Million USD) (2013-2025)
Figure India Complex Regional Pain Syndrome Treatment Market Size (Million USD) (2013-2025)
Table Complex Regional Pain Syndrome Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Complex Regional Pain Syndrome Treatment in
Figure Manufacturing Process Analysis of Complex Regional Pain Syndrome Treatment
Figure Industry Chain Structure of Complex Regional Pain Syndrome Treatment
Table Capacity and Commercial Production Date of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
Table Manufacturing Plants Distribution of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
Table R&D Status and Technology Source of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
Table Raw Materials Sources Analysis of Global Complex Regional Pain Syndrome Treatment Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Complex Regional Pain Syndrome Treatment E
Figure Global E Complex Regional Pain Syndrome Treatment Market Size (Volume) and Growth Rate
Figure Global E Complex Regional Pain Syndrome Treatment Market Size (Value) and Growth Rate
Table E Global Complex Regional Pain Syndrome Treatment Capacity and Growth Rate
Table Global Complex Regional Pain Syndrome Treatment Capacity (K Pcs) List (Company Segment)
Table E Global Complex Regional Pain Syndrome Treatment Sales (K Pcs) and Growth Rate
Table Global Complex Regional Pain Syndrome Treatment Sales (K Pcs) List (Company Segment)
Table E Global Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Table Global Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Complex Regional Pain Syndrome Treatment E
Figure North America E Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Figure North America Complex Regional Pain Syndrome Treatment Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Complex Regional Pain Syndrome Treatment E
Figure Europe E Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Figure Europe Complex Regional Pain Syndrome Treatment Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Complex Regional Pain Syndrome Treatment E
Figure China E Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Figure China Complex Regional Pain Syndrome Treatment Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Complex Regional Pain Syndrome Treatment E
Figure Japan E Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Figure Japan Complex Regional Pain Syndrome Treatment Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Complex Regional Pain Syndrome Treatment E
Figure Southeast Asia E Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Figure Southeast Asia Complex Regional Pain Syndrome Treatment Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Complex Regional Pain Syndrome Treatment E
Figure India E Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs)
Figure India Complex Regional Pain Syndrome Treatment Sales Market Share
Table Global E Complex Regional Pain Syndrome Treatment Sales (K Pcs) by Type
Table Different Types Complex Regional Pain Syndrome Treatment Product Interview Price
Table Global E Complex Regional Pain Syndrome Treatment Sales (K Pcs) by Application
Table Different Application Complex Regional Pain Syndrome Treatment Product Interview Price
Table Abiogen Pharma SpA Information List
Table Product Overview
Table Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Abiogen Pharma SpA Complex Regional Pain Syndrome Treatment Business Region Distribution
Table Axsome Therapeutics, Inc. Information List
Table Product Overview
Table Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Axsome Therapeutics, Inc. Complex Regional Pain Syndrome Treatment Business Region Distribution
Table Grunenthal GmbH Information List
Table Product Overview
Table Grunenthal GmbH Complex Regional Pain Syndrome Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Grunenthal GmbH Complex Regional Pain Syndrome Treatment Business Region Distribution
Table Mallinckrodt Plc Information List
Table Product Overview
Table Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Mallinckrodt Plc Complex Regional Pain Syndrome Treatment Business Region Distribution
Figure Global 2018-2025 Complex Regional Pain Syndrome Treatment Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 Complex Regional Pain Syndrome Treatment Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Complex Regional Pain Syndrome Treatment Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 Complex Regional Pain Syndrome Treatment Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Complex Regional Pain Syndrome Treatment by Type 2018-2025
Table Global Consumption Volume (K Pcs) of Complex Regional Pain Syndrome Treatment by Application 2018-2025
Table Traders or Distributors with Contact Information of Complex Regional Pain Syndrome Treatment by Region
Segments Analysis
By Product / Drug Type
-
T-121
Novel centrally acting analgesic candidates -
NTRX-07
Targeted neuropathic pain modulation therapies -
Neridronic Acid
Bisphosphonate-based therapy with established clinical use in CRPS -
Other Therapies
Includes corticosteroids, anticonvulsants, antidepressants, NMDA antagonists, and emerging biologics
By Drug Class (Expanded Segmentation)
-
Bisphosphonates
-
NMDA Receptor Antagonists
-
Anticonvulsants
-
Antidepressants
-
Opioid & Non-Opioid Analgesics
-
Anti-Inflammatory Agents
By Route of Administration (New Segment)
-
Oral
-
Intravenous
-
Intrathecal
-
Topical
By Application / End User
-
Hospitals
Primary centers for diagnosis and advanced pain management -
Clinics
Pain management and specialty neurology clinics -
Others
Rehabilitation centers and home-care settings
Key Market Players
Major Manufacturers
-
Abiogen Pharma SpA
-
Axsome Therapeutics Inc
-
Grünenthal GmbH
-
Mallinckrodt Plc
Additional & Emerging Players (Added)
-
Pfizer
-
Novartis
-
Eli Lilly
-
Teva Pharmaceutical Industries
-
Johnson & Johnson